-

$undefined

N/A

(N/A)

Theratechnologies Inc :THTX

Location: | Industry: | Sector:

Market Cap

NaN

52 Wk Range

$ - $

Previous Close

$N/A

Open

$N/A

Day Range

N/A - N/A

Volume

N/A

Avg Volume

N/A

Enterprise Value

103.8M

Cash

38.86M

Avg Qtr Burn

-375K

Short % of Float

0.03%

Insider Ownership

1.25%

Institutional Own.

50.07%

Qtr Updated

08/31/24

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
Trogarzo® 90-Second Intravenous (IV) Details Human immunodeficiency virus	Approved Quarterly sales	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Tesamorelin (F8 Formulation) Details Human immunodeficiency virus, Abdominal Fat	PDUFA Approval decision	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Trogarzo® Intramuscular (IM) Details Human immunodeficiency virus	BLA Acceptance for review	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
TH1902 / Sudocetaxel Zendusortide Details Cancer, Ovarian cancer	Phase 1 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.